Anthrax News and Research

RSS
Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in wild and domestic lower vertebrates (cattle, sheep, goats, camels, antelopes, and other herbivores), but it can also occur in humans when they are exposed to infected animals or tissue from infected animals.

Anthrax is most common in agricultural regions where it occurs in animals. These include South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and the Middle East. When anthrax affects humans, it is usually due to an occupational exposure to infected animals or their products. Workers who are exposed to dead animals and animal products from other countries where anthrax is more common may become infected with B. anthracis (industrial anthrax). Anthrax outbreaks occur in the United States on an annual basis in livestock and wild game animals such as deer.

Anthrax infection can occur in three forms: cutaneous (skin), inhalation, and gastrointestinal. B. anthracis spores can live in the soil for many years, and humans can become infected with anthrax by handling products from infected animals or by inhaling anthrax spores from contaminated animal products. Anthrax can also be spread by eating undercooked meat from infected animals. It is rare to find infected animals in the United States.
Elusys presents positive results of obiltoxaximab for treating inhalational anthrax, post-exposure prophylaxis

Elusys presents positive results of obiltoxaximab for treating inhalational anthrax, post-exposure prophylaxis

Investigators develop microbiome map of New York City subway system

Investigators develop microbiome map of New York City subway system

Soligenix's SGX301 receives FDA 'Fast Track' designation for CTCL treatment

Soligenix's SGX301 receives FDA 'Fast Track' designation for CTCL treatment

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Soligenix closes previously announced registered public offering

Soligenix closes previously announced registered public offering

ADI develops ELISA test kits for detection of Ebola viral protein antibodies

ADI develops ELISA test kits for detection of Ebola viral protein antibodies

IU Bloomington biologists to receive funding from NSF’s Dimensions of Biodiversity Program

IU Bloomington biologists to receive funding from NSF’s Dimensions of Biodiversity Program

Pharmaceutical industry withdraws from the antibiotic space

Pharmaceutical industry withdraws from the antibiotic space

LLNL scientists issued patent for producing antimicrobial compounds to fight superbugs

LLNL scientists issued patent for producing antimicrobial compounds to fight superbugs

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Rice University researchers confirm potent synthesis of natural tetracycline

Rice University researchers confirm potent synthesis of natural tetracycline

OMRF receives $14.5 million grant from NIH to continue research on anthrax

OMRF receives $14.5 million grant from NIH to continue research on anthrax

CDC report blames researcher's haste for bird flu virus mishandling

CDC report blames researcher's haste for bird flu virus mishandling

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

Senate could vote on VA nominee's confirmation before the August break

Senate could vote on VA nominee's confirmation before the August break